Article
On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis
27 Apr 2021
Abstract excerpt
Cystic fibrosis (CF) is a severe genetic disease for which curative treatment is still lacking. Next generation biotechnologies and more efficient cell-based and in vivo disease models are accelerating the development of novel therapies for CF. Gene editing tools, like CRISPR-based systems, can be used to make targeted modifications in the genome, allowing to correct mutations directly in the Cystic Fibrosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
